ATR
Aptargroup·NYSE
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 6
Bearish signal 0
Dividend Aristocrat
Consensus Rating "Buy"
Ample Liquidity
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ATR
Aptargroup, Inc.
A global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services
265 Exchange Drive, Suite 301, Crystal Lake, IL 60014
--
Aptargroup, Inc., was incorporated in Delaware in 1992. The company is a global leader in the design and manufacture of drug delivery, dispensing and protection technologies serving the pharmaceutical, fragrance, beauty, food, beverage and personal care markets. Its product portfolio includes distribution pumps, bottle caps, aerosol valves, elastomer components, active material science solutions and digital health technology, serving approximately 5,000 customers worldwide.
Company Financials
EPS
ATR has released its 2025 Q4 earnings. EPS was reported at 1.25, versus the expected 1.23, beating expectations. The chart below visualizes how ATR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ATR has released its 2025 Q4 earnings report, with revenue of 962.74M, reflecting a YoY change of 13.52%, and net profit of 74.27M, showing a YoY change of -26.37%. The Sankey diagram below clearly presents ATR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
